To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment (CANINE)
Cancer Therapy and Immunogenicity of COVID Vaccine (CANINE Trial)
Sponsor: University of Kansas Medical Center
This observational or N/A phase trial investigates Breast Cancer and Lung Cancer and is currently ongoing. University of Kansas Medical Center leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
6 versions recorded-
May 2025 — Present [monthly]
Unknown
Status: Active Not Recruiting → Unknown
-
Sep 2024 — May 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
May 2023 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
May 2022 — May 2023 [monthly]
Recruiting
▶ Show 1 earlier version
-
Apr 2021 — May 2022 [monthly]
Recruiting
First recorded
Feb 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Kansas Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .